Vitamin D and omega-3 polyunsaturated fatty acid supplementation in athletes with exercise-induced bronchoconstriction: a pilot study.

Abstract:

OBJECTIVE:The aim of this pilot study was to determine the combined effect of vitamin D and omega-3 polyunsaturated fatty acid (PUFA) supplementation on airway function and inflammation in recreational athletes with exercise-induced bronchoconstriction (EIB). METHODS:Ten recreational athletes with EIB participated in a single-blind, placebo-controlled trial over six consecutive weeks. All subjects attended the laboratory on three occasions. Each visit was separated by a period of 3 weeks: visit 1 (usual diet), visit 2 (placebo) and visit 3 (SMARTFISH® NutriFriend 2000; 30 µg vitamin D3-3000 mg eicosapentaenoic acid, 3000 mg docosahexaenoic acid) consumed once daily for a period of 3 weeks. Venous blood was collected at the beginning of each trial to determine vitamin D status. Spirometry was performed pre- and post-eucapnic voluntary hyperpnoea (EVH). RESULTS:The Maximum fall in FEV1 (ΔFEV1max) post-EVH was not different between visits (usual diet: -15.9 ± 3.6%, placebo: -16.1 ± 6.1%, vitamin D + omega-3 PUFA: -17.8 ± 7.2%). Serum vitamin D remained unchanged between visits. CONCLUSION:Vitamin D and omega-3 PUFA supplementation does not attenuate the reduction in lung function post-EVH. This finding should be viewed as preliminary until the results of randomised controlled trials are made available.

journal_name

Expert Rev Respir Med

authors

Price OJ,Hull JH,Howatson G,Robson-Ansley P,Ansley L

doi

10.1586/17476348.2015.1036032

subject

Has Abstract

pub_date

2015-06-01 00:00:00

pages

369-78

issue

3

eissn

1747-6348

issn

1747-6356

journal_volume

9

pub_type

杂志文章
  • Recent advances in optical coherence tomography for the diagnoses of lung disorders.

    abstract::There have been many advances in the field of diagnostic and therapeutic pulmonary medicine in the past several years, with major progress in the field of imaging. Optical coherence tomography (OCT) is a high-resolution (micron level) imaging modality currently being advanced with the potential to image airway wall st...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.11.59

    authors: Hou R,Le T,Murgu SD,Chen Z,Brenner M

    更新日期:2011-10-01 00:00:00

  • Dust-mite inducing asthma: what advice can be given to patients?

    abstract::Introduction: Amongst allergic asthmatics, high allergen exposure increases asthma severity. However, there is no consensus on the role of mite allergen avoidance in the management of asthma, and various guidelines differ in their recommendations. Areas covered: Several systematic reviews/meta-analyses on mite avoidan...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2019.1651647

    authors: Custovic A,Murray CS,Simpson A

    更新日期:2019-10-01 00:00:00

  • Combination therapy for the treatment of pulmonary mold infections.

    abstract:INTRODUCTION:Pulmonary mold infections are caused by ubiquitous organisms found in soil, water, and decaying vegetation, including Aspergillus spp., the Mucormycetes, hyaline molds, and dematiaceous (black) molds. Areas covered: These infections are often a challenge to diagnose and even more difficult to treat. Recent...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2017.1325322

    authors: McCarthy MW,Petraitis V,Walsh TJ

    更新日期:2017-06-01 00:00:00

  • Budesonide/formoterol in the treatment of asthma.

    abstract::Budesonide/formoterol is a combination of an inhaled corticosteroid plus a long-acting beta(2)-agonist available as a dry-powder inhaler for the indication of asthma and chronic obstructive pulmonary disease in various countries outside of the USA and as a pressurized metered-dose inhaler in the USA for the indication...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2.5.551

    authors: Lee C,Corren J

    更新日期:2008-10-01 00:00:00

  • Unmet needs in cystic fibrosis: the next steps in improving outcomes.

    abstract:INTRODUCTION:Cystic fibrosis (CF) outcomes and survival have improved over the last century primarily due to advancements in antibiotics, nutritional, and pulmonary therapies. Reviewed here are the significant unmet needs that exist for individuals with CF. Areas covered: With the recent development of medications that...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1483723

    authors: West NE,Flume PA

    更新日期:2018-07-01 00:00:00

  • Management of incidental pulmonary nodules: current strategies and future perspectives.

    abstract::Introduction: Detection and characterization of pulmonary nodules is an important issue, because the process is the first step in the management of lung cancers.Areas covered: Literature review was performed on May 15 2019 by using the PubMed, US National Library of Medicine National Institutes of Health, and the Nati...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2020.1697853

    authors: Kim TJ,Kim CH,Lee HY,Chung MJ,Shin SH,Lee KJ,Lee KS

    更新日期:2020-02-01 00:00:00

  • Olodaterol + tiotropium bromide for the treatment of COPD.

    abstract::Patients suffering from COPD not controlled by a single bronchodilator should be given two bronchodilators with different mechanisms of action. Addition of a LABA to a LAMA induces a larger bronchodilation than that obtained with the LAMA as monotherapy and also improves many patient-reported outcomes. Since the clini...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.2016.1156538

    authors: Calzetta L,Ciaprini C,Puxeddu E,Cazzola M

    更新日期:2016-04-01 00:00:00

  • Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR.

    abstract::The hallmarks of allergic bronchial asthma arise from chronic airway inflammation. Thus, elucidating the mechanisms regulating the maintenance of this chronic inflammatory response is key to understanding asthma pathogenesis. To date, it is not clear whether a predominance of proinflammatory factors or a reduced capac...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.1109452

    authors: Lunding L,Schröder A,Wegmann M

    更新日期:2015-01-01 00:00:00

  • Thirty-five alternatives to positive airway pressure therapy for obstructive sleep apnea: an overview of meta-analyses.

    abstract:INTRODUCTION:Positive airway pressure (PAP) devices are generally considered to be the first-line treatment of choice for most adults with obstructive sleep apnea (OSA). However, there are several alternatives. It is important for patients and their sleep providers to be aware of the most up-to-date information regardi...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2018.1522253

    authors: Camacho M,Chang ET,Neighbors CLP,Noller MW,Mack D,Capasso R,Kushida CA

    更新日期:2018-11-01 00:00:00

  • The long-lasting effects of the acute respiratory distress syndrome.

    abstract::Introduction: Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury common in critically ill patients and characterized by significant morbidity and mortality. It frequently manifests long-lasting effects beyond hospitalization, from cognitive impairment to physical weakness.Areas covered: S...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1743182

    authors: Mart MF,Ware LB

    更新日期:2020-06-01 00:00:00

  • Current challenges in the recognition, prevention and treatment of perioperative pulmonary atelectasis.

    abstract::Innovations in surgery have significantly increased the number of procedures performed every year. While more individuals benefit from better surgical techniques and technology, a larger group of patients previously deemed ineligible for surgery now undergo high-complexity surgical procedures. Despite continuous impro...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2015.996134

    authors: Restrepo RD,Braverman J

    更新日期:2015-02-01 00:00:00

  • The pragmatic role of FEF25-75 in asymptomatic subjects, allergic rhinitis, asthma, and in military setting.

    abstract::Introduction: The forced expiratory flow between 25% and 75% of forced vital capacity (FEF25-75) is a spirometry parameter that may be useful in many clinical settings. Values <65% of predicted have been defined as abnormal.Areas covered: The current report discusses the clinical value of FEF25-75 in different setting...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2019.1674649

    authors: Ciprandi G,Cirillo I

    更新日期:2019-12-01 00:00:00

  • Mesenchymal stem cells for repair of the airway epithelium in asthma.

    abstract::The airway epithelium is constantly faced with inflammatory and potentially injurious stimuli. Following damage, rapid repair mechanisms involving proliferation and differentiation of resident progenitor and stem cell pools are necessary in order to maintain a protective barrier. In asthma, evidence pointing to a comp...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.10.72

    authors: Knight DA,Rossi FM,Hackett TL

    更新日期:2010-12-01 00:00:00

  • The role of desmosines as biomarkers for chronic obstructive pulmonary disease.

    abstract::Since chronic obstructive pulmonary disease (COPD) has a progressive and major impact on health management, many aspects of this disorder, including development of effective and reliable biomarkers to monitor disease progression, are under intensive investigation. A huge amount of data, accumulated over the years, hav...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.13.4

    authors: Iadarola P,Luisetti M

    更新日期:2013-04-01 00:00:00

  • Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease.

    abstract::Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and a scavenging effect on free oxidant radicals. Erdosteine is a prodrug and metabolite I is the active metabolite of erdoste...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/17476348.1.3.307

    authors: Moretti M

    更新日期:2007-12-01 00:00:00

  • The emerging phenomenon of electronic cigarettes.

    abstract::The need for novel and more effective approaches to tobacco control is unquestionable. The electronic cigarette is a battery-powered electronic nicotine delivery system that looks very similar to a conventional cigarette and is capable of emulating smoking, but without the combustion products accountable for smoking's...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.11.92

    authors: Caponnetto P,Campagna D,Papale G,Russo C,Polosa R

    更新日期:2012-02-01 00:00:00

  • Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea.

    abstract::Introduction: Obstructive sleep apnea (OSA) is highly prevalent and constitutes a major health hazard. Current pharmacotherapy is ineffective in correcting sleep-disordered breathing and is used adjunctively to address residual sleepiness. A new drug, solriamfetol, a selective norepinephrine-dopamine reuptake inhibito...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1541742

    authors: Abad VC,Guilleminault C

    更新日期:2018-12-01 00:00:00

  • Ultrasound in the management of pleural disease.

    abstract:INTRODUCTION:Pleural disease encompasses a large range of conditions, is a common presentation to the acute medical take and often requires comprehensive investigation and treatment. Ultrasound is well recognised as a useful investigative tool in pleural disease especially in the field of pleural effusion, pleural thic...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2017.1300531

    authors: Mercer RM,Psallidas I,Rahman NM

    更新日期:2017-04-01 00:00:00

  • Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?

    abstract::Chronic obstructive pulmonary disease is an inflammatory disorder characterized by airflow limitation. Its cardinal symptom is dyspnea, which develops gradually with even low levels of exercise. Bronchodilators (BDs) are the most effective drugs for relieving dyspnea. Two main types of BD are currently available, β-mi...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.13.18

    authors: Baloira A

    更新日期:2013-04-01 00:00:00

  • Effects of anemia on the survival of patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

    abstract:OBJECTIVES:Anemia is often seen in chronic obstructive pulmonary disease (COPD) patients. However, the implications of anemia on the outcomes of patients with COPD is not clearly known. Therefore, we conducted a systematic review and meta-analysis to evaluate the effects of anemia on the morbidity and mortality of pati...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1816468

    authors: Xu Y,Hu T,Ding H,Chen R

    更新日期:2020-12-01 00:00:00

  • Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.

    abstract::The Understanding Potential Long-term Improvements in Function with Tiotropium (UPLIFT) trial was a global 4-year randomized placebo-controlled clinical trial that evaluated the long-term impact of tiotropium bromide 18 microg once daily on the accelerated age-related decline in pre- and post-bronchodilator forced exp...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.10.23

    authors: Tashkin DP

    更新日期:2010-06-01 00:00:00

  • An overview of the available treatments for chronic cavitary pulmonary aspergillosis.

    abstract:INTRODUCTION:Chronic pulmonary aspergillosis (CPA) is a chronic lung infection caused by Aspergillus fumigatus, that complicates structural lung diseases. Of the different types of CPA, chronic cavitary pulmonary aspergillosis (CCPA) is the most common form. The mainstay of treatment of CCPA is oral triazoles. However,...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2020.1750956

    authors: Sehgal IS,Dhooria S,Muthu V,Prasad KT,Agarwal R

    更新日期:2020-07-01 00:00:00

  • Risks associated with lung transplantation in cystic fibrosis patients.

    abstract:INTRODUCTION:Survival after lung transplantation lags behind outcomes of other solid organ transplants, and complications from lung transplant are the second most common cause of death in cystic fibrosis. Evolving surgical techniques, therapeutics, and perioperative management have improved short-term survival after lu...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1522254

    authors: Li SS,Tumin D,Krone KA,Boyer D,Kirkby SE,Mansour HM,Hayes D Jr

    更新日期:2018-11-01 00:00:00

  • Methicillin-resistant Staphylococcus aureus pneumonia in adults.

    abstract::Methicillin-resistant Staphylococcus aureus (MRSA) has become one of the leading etiologies of nosocomial pneumonia as a result of an increase in staphylococcal infections caused by methicillin-resistant strains paired with extended ventilatory support of critically, and often, chronically ill patients. The prevalence...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/17476348.2014.940323

    authors: Woods C,Colice G

    更新日期:2014-10-01 00:00:00

  • Bench-to-bedside review: the role of nitric oxide in sepsis.

    abstract::Sepsis is a state of systemic inflammation directed at microbes or their toxins in blood or tissues. Nitric oxide (NO) is one of many vasoactive molecules released from a variety of cell types during sepsis. Almost two decades ago, NO emerged as a potential therapeutic target in sepsis. NO produced by the constitutive...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1586/ers.09.39

    authors: De Cruz SJ,Kenyon NJ,Sandrock CE

    更新日期:2009-10-01 00:00:00

  • Current and future molecular approaches in the diagnosis of cystic fibrosis.

    abstract:INTRODUCTION:Cystic Fibrosis is among the first diseases to have general population genetic screening tests and one of the most common indications of prenatal and preimplantation genetic diagnosis for single gene disorders. During the past twenty years, thanks to the evolution of diagnostic techniques, our knowledge of...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2018.1457438

    authors: Bergougnoux A,Taulan-Cadars M,Claustres M,Raynal C

    更新日期:2018-05-01 00:00:00

  • Second-line therapy of squamous non-small cell lung cancer: an evolving landscape.

    abstract:INTRODUCTION:The treatment of lung cancer has radically changed over the last few years. The discovery of druggable oncogenic alterations and the introduction of immunotherapy have provided lung cancer patients with the possibility of more efficient and less toxic therapeutic alternatives than chemotherapy. In the case...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1080/17476348.2017.1326822

    authors: Lazzari C,Karachaliou N,Gregorc V,Bulotta A,Gonzalez-Cao M,Verlicchi A,Altavilla G,Rosell R,Santarpia M

    更新日期:2017-06-01 00:00:00

  • Acute oxygen therapy: a cross-sectional study of prescribing practices at an English hospital immediately before COVID-19 pandemic.

    abstract:BACKGROUND:Approximately 14% of UK hospital in-patients receive supplemental oxygen therapy, only 57% have valid prescriptions. Oxygen must be optimally prescribed to ensure maximal therapeutic response whilst minimizing adverse outcomes (including fatality). This study investigates prescription compliance. METHODS:Al...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2021.1826316

    authors: Barrett R,Catangui E,Scott R

    更新日期:2020-10-14 00:00:00

  • Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?

    abstract:INTRODUCTION:There is an ongoing need for additional interventions in idiopathic pulmonary fibrosis (IPF) as antifibrotic drugs currently available only inhibit and do not stall disease progression. Vitamin K is a co-factor for the activation of coagulation factors. However, it is also required to activate proteins wit...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章

    doi:10.1080/17476348.2018.1424544

    authors: De Brouwer B,Piscaer I,Von Der Thusen JH,Grutters JC,Schutgens RE,Wouters EF,Janssen R

    更新日期:2018-03-01 00:00:00

  • Growing old with asthma: what are the changes and challenges?

    abstract::Asthma is a disease that affects approximately 7% of adults residing in the USA; the prevalence is even greater in children and approaches 10%. The CDC has reported that the overall prevalence of lifetime asthma is 10.5%. New-onset asthma is most often seen in children and is associated with atopy; however, the majori...

    journal_title:Expert review of respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1586/ers.10.12

    authors: Braman SS

    更新日期:2010-04-01 00:00:00